Alpha Cognition Inc.

ACOG

Healthcare Biotechnology

Alpha Cognition Inc.’s revenue for fiscal 2025 (year ended December 2025) was $10.2 million.

Revenue
+267.6%
EPS
+51.2%
Free cash flow
−109.3%

Quarter to June 2026, against a year earlier

8.29 0.14 +1.72%
Market cap
$180.5M
P/E
n/m
Fwd P/E
n/m
Dividend yield
—
F-score
n/a
ROIC
−144.7%
Net debt / EBITDA
2.9×
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
P/E ratio
0.00 — — — — — —
P/S ratio
11.24 — — — — — —
Altman Z-Score
2.55 — — — — — —
P/FCF ratio
0.00 — — — — — —
Altman Z″-Score (non-manufacturers)
3.69 — — — — — —
P/Operating CF
(16.64) — — — — — —
P/B ratio
1.84 — — — — — —
EV/Sales
4.87 — — — — — —
EV/EBITDA
0.00 — — — — — —
EV/FCF
(2.40) — — — — — —
Current Ratio
8.65 15.00 0.73 0.58 6.75 2.15 17.43
Net Debt/EBITDA
2.92 4.07 0.15 0.16 0.94 0.44 0.77
Debt/Equity
0.00 0.00 0.00 0.00 0.00 199.44 0.16
ROE
(40.68%) (86.00%) 456.96% (314.28%) (432.14%) (219.92%) 0.00%
ROA
(31.69%) (55.61%) (509.46%) (153.05%) (183.38%) (78.00%) 0.00%
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% (685.00%)
Return on Tangible Assets
(29.44%) (31.51%) 1,977.83% 704.22% (188.28%) (140.07%) (125.43%)
Average Days of Receivables
151.28 — 0.00 — — 0.00 0.00
Earnings Yield
(18.31%) — — — — — —
Free Cash Flow Yield
(18.03%) — — — — — —
Free Cash Flow per Share
(1.17) (1.07) (2.45) (3.40) (4.66) (3.17) (2.03)
Book value per Share
3.54 5.39 (1.31) (0.49) 4.23 0.01 4.17
Free Cash Flow
(20.67) (7.78) (8.80) (9.25) (9.94) (5.45) (2.55)
EV/EBIT
0.00 — — — — — —
Other line items

Show all line items

Columns are period end dates · fundamentals updated 26 Oct 2026